Campione Elena, Di Prete Monia, Diluvio Laura, Bianchi Luca, Orlandi Augusto
Department of Dermatology.
Department of Pathology, University of Rome Tor Vergata, Rome, Italy.
Clin Cosmet Investig Dermatol. 2016 Nov 7;9:405-409. doi: 10.2147/CCID.S111305. eCollection 2016.
Actinic keratosis (AK) is considered as superficial squamous cell carcinoma. Chronic sun exposure plays a central role in its pathogenesis. In particular, ultraviolet B radiation causes direct damage to the DNA, producing pyrimidine dimers that suppress the protective role of p53. Other risk factors include advanced age, male sex, and fair skin type. Even some drugs used for treating blood hypertension, such as thiazide diuretics, can increase the risk of developing AK. Their photosensitizing action seems to be connected with reactive oxygen species production. We report our experience with ten patients affected by multiple AK, in therapy with thiazide diuretics, treated by ingenol mebutate gel. AK was clinically and dermoscopically evaluated at baseline and after 30 days from the beginning of the treatment. Moreover, patients were screened for vitamin D values and reported a general hypovitaminosis status. To our knowledge, we report for the first time the efficacy of ingenol mebutate gel in this group of patients, particularly at risk of developing AK.
光化性角化病(AK)被认为是浅表性鳞状细胞癌。长期日晒在其发病机制中起核心作用。特别是紫外线B辐射会对DNA造成直接损伤,产生嘧啶二聚体,从而抑制p53的保护作用。其他风险因素包括高龄、男性以及白皙的皮肤类型。甚至一些用于治疗高血压的药物,如噻嗪类利尿剂,也会增加患AK的风险。它们的光敏作用似乎与活性氧的产生有关。我们报告了10例患有多发性AK且正在接受噻嗪类利尿剂治疗的患者使用鬼臼毒素酯凝胶治疗的经验。在基线时以及治疗开始30天后,对AK进行了临床和皮肤镜评估。此外,还对患者的维生素D值进行了筛查,结果显示普遍存在维生素缺乏状态。据我们所知,我们首次报告了鬼臼毒素酯凝胶在这类患者中的疗效,尤其是在有患AK风险的患者中。